Viewing Study NCT06492759


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-02-24 @ 8:13 PM
Study NCT ID: NCT06492759
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2024-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Sponsor: Emory University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2026-01-31
Start Date Type: ESTIMATED
Primary Completion Date: 2027-02-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-02-13
Completion Date Type: ESTIMATED
First Submit Date: 2024-07-01
First Submit QC Date: None
Study First Post Date: 2024-07-09
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-11
Last Update Post Date: 2025-12-16
Last Update Post Date Type: ESTIMATED